Search
Sep 26, 2024
Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference
Matt Biegler summarizes a breast cancer panel from the conference and talks about recent data from Relay and upcoming data from Gilead....
Sep 21, 2023
Houston Oncology Summit: Oppenheimer analyst Matthew Biegler talks about synthetic lethality
He describes how PARP inhibitors were initial successes and where the field is going now beyond PARP with new targets.